(ADPV) Series Portfolios Trust - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US81752T5368

ADPV: Large-Cap Stocks, Mid-Cap Stocks, REITs, Equity Securities

The Adaptive Select ETF (ADPV) is an actively managed exchange-traded fund that seeks to achieve long-term capital appreciation by investing in a portfolio of large-cap U.S. equity securities during periods of broad market uptrends. The funds investment strategy focuses on common stocks of large-capitalization companies, with the flexibility to invest in REITs that are among the 1,000 largest U.S.-listed stocks, allowing for a diversified exposure to the U.S. equity market.

Given its non-diversified nature, the funds performance is likely to be heavily influenced by the stocks it holds in its portfolio. As an actively managed ETF, the funds management team will actively make decisions to buy and sell securities to achieve its investment objective. The funds investment in large-cap U.S. stocks is expected to provide a relatively stable source of returns, while its ability to invest in REITs adds a layer of diversification to its portfolio.

Analyzing the and , we can observe that the funds current price is $34.52, slightly above its 20-day and 50-day simple moving averages, indicating a positive short-term trend. The 200-day SMA is at $34.59, suggesting that the fund is currently trading slightly below its long-term trend. With an AUM of $121.53M, the fund has a moderate size, which may impact its liquidity. The ATR of 0.19 (0.55%) indicates relatively low volatility.

Based on the available data, a forecast for ADPV can be made. Considering the funds current price is near its long-term trend and the relatively low volatility, we can expect the fund to continue its upward trend in the short term, potentially reaching $35.50 within the next few weeks. However, if the market experiences a downturn, the funds non-diversified nature may lead to a more significant decline. Therefore, investors should closely monitor the funds performance and adjust their strategies accordingly.

Additional Sources for ADPV ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

ADPV ETF Overview

Market Cap in USD 119m
Category Mid-Cap Blend
TER 1.00%
IPO / Inception 2022-11-03

ADPV ETF Ratings

Growth Rating 54.9
Fundamental -
Dividend Rating 45.8
Rel. Strength 6.21
Analysts -
Fair Price Momentum 34.22 USD
Fair Price DCF -

ADPV Dividends

Dividend Yield 12m 0.68%
Yield on Cost 5y 0.97%
Annual Growth 5y 55.96%
Payout Consistency 96.1%
Payout Ratio %

ADPV Growth Ratios

Growth Correlation 3m 39.1%
Growth Correlation 12m 59.9%
Growth Correlation 5y 84.8%
CAGR 5y 15.28%
CAGR/Max DD 5y 0.68
Sharpe Ratio 12m 0.48
Alpha 8.34
Beta 0.845
Volatility 22.80%
Current Volume 9.3k
Average Volume 20d 12.2k
What is the price of ADPV shares?
As of June 26, 2025, the stock is trading at USD 35.96 with a total of 9,329 shares traded.
Over the past week, the price has changed by +1.50%, over one month by +4.78%, over three months by +4.69% and over the past year by +19.83%.
Is Series Portfolios Trust a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, Series Portfolios Trust (NYSE ARCA:ADPV) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 54.94 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ADPV is around 34.22 USD . This means that ADPV is currently overvalued and has a potential downside of -4.84%.
Is ADPV a buy, sell or hold?
Series Portfolios Trust has no consensus analysts rating.
What are the forecasts for ADPV share price target?
According to our own proprietary Forecast Model, ADPV Series Portfolios Trust will be worth about 39.1 in June 2026. The stock is currently trading at 35.96. This means that the stock has a potential upside of +8.84%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 39.1 8.8%